RECRUITING

The Youth Opioid Recovery Support (YORS) Intervention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Youth are disproportionately affected by the current opioid crisis with catastrophic consequences, and young adults with opioid use disorder (OUD) often struggle with adherence to relapse prevention medications. The Youth Opioid Recovery Support (YORS) model is a promising, innovative, wrap-around approach that addresses barriers to medication adherence and treatment engagement in an effort to improve public health outcomes in this vulnerable young adult population. This study seeks to refine the YORS intervention through stakeholder input and pilot iterative testing followed by an efficacy randomized controlled trial. This project will significantly contribute to our knowledge base of practical strategies to address the opioid crisis.

Official Title

The Youth Opioid Recovery Support (YORS) Intervention: An Assertive Community Treatment Model for Improving Medication Adherence in Young Adults With Opioid Use Disorder

Quick Facts

Study Start:2020-02-17
Study Completion:2024-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04173416

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 28 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18-28
  2. * OUD diagnosis
  3. * Willing (intending) to receive treatment with XR-NTX or XR-BUP under the care of a MTC physician/nurse practitioner
  4. * Willingness to designate family member (or other suitable treatment significant other) for treatment involvement (i.e., a treatment significant other; TSO)
  1. * Psychiatric or medical instability (e.g., suicidality, psychosis, Sickle Cell disease with frequent crises) that would preclude participation in the trial
  2. * Living situation (location greater than 75 miles from the center, homelessness) that would preclude participation in the trial

Contacts and Locations

Study Contact

Marc Fishman, MD
CONTACT
410-233-1400
mjfishman@comcast.net
Kevin Wenzel, PhD
CONTACT
410-233-1400
kwenzel@mountainmanor.org

Principal Investigator

Marc Fishman, MD
PRINCIPAL_INVESTIGATOR
Maryland Treatment Centers

Study Locations (Sites)

Mountain Manor Treatment Center
Baltimore, Maryland, 21229
United States

Collaborators and Investigators

Sponsor: Potomac Health Foundations

  • Marc Fishman, MD, PRINCIPAL_INVESTIGATOR, Maryland Treatment Centers

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-02-17
Study Completion Date2024-08-31

Study Record Updates

Study Start Date2020-02-17
Study Completion Date2024-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid-use Disorder
  • Medication Adherence